Drug Approval | December 03, 2021
Unichem Labs gets ANDA approval for schizophrenia medicine
The product will be commercialized from Unichem's Ghaziabad plant
The product will be commercialized from Unichem's Ghaziabad plant
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has has 10 existing labs in India
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
Filing marks first protein-based vaccine submitted to MHRA for authorization
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology
It is a recombinant nanoparticle protein-based vaccine
Subscribe To Our Newsletter & Stay Updated
